Zatolochina K.E. - list of publications

SAFETY AND TOLERABILITY OF NSAIDS: FOCUS ON ACECLOFENAC

Article

Ushkalova E.A., Zyryanov S.K., Zalolochina K.E.

Медицинский совет. ООО «ГРУППА РЕМЕДИУМ». 2019. P. 110-120

SERIOUS ADVERSE DRUG REACTIONS WITH LETHAL OUTCOMES: ANALYSIS OF THE RUSSIAN PHARMACOVIGILANCE DATABASE

Article

Shmaevskij P.E., Kosyakina N., Cigura D.A., Zatolochina K.E., Zyryanov S.K., Asetskaya I.L., Kazakov A.S.

SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. Российский университет дружбы народов (РУДН). 2019. 142 p.

INTERNATIONAL DRUG SAFETY MONITORING

Article

Kazakov A.S., Shubnikova E.V., Darmostukova M.A., Snegireva I.I., Kutekhova G.V., Zatolochina K.E., Velts N.Y., Kaperko D.A., Olefir Y.V.

Безопасность и риск фармакотерапии. Федеральное государственное бюджетное учреждение "Научный центр экспертизы средств медицинского применения" Министерства здравоохранения Российской Федерации. Vol. 7. 2019. P. 120-126

MURAMYLDIPEPTIDE - BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Terapevticheskii Arkhiv. Vol. 91. 2019. P. 122-127

ANALYSIS OF ADVERSE DRUG REACTIONS IN ELDERLY PATIENTS ACCORDING TO THE DATABASE OF SPONTANEOUS REPORTS

Article

Zatolochina K.E., Ushkalova E.A., Zyryanov S.K., Polivanov V.A.

Хирург. 2019. P. 69-73

INTERFERON BETA: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS AND EVALUATION OF POSSIBILITY OF SIGNAL IDENTIFICATION

Article

Zatolochina K.E., Snegireva I.I., Kazakov A.S., Lepakhin V.K.

Безопасность и риск фармакотерапии. Федеральное государственное бюджетное учреждение "Научный центр экспертизы средств медицинского применения" Министерства здравоохранения Российской Федерации. Vol. 7. 2019. P. 84-92

THE ANALYSIS OF ADVERSE DRUG REACTIONS IN THE ELDERLY PATIENTS

Article

Tsigura Darya, Shmaevsky Pavel, Zatolochina K.E., Ushkalova E.A.

SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. Российский университет дружбы народов (РУДН). 2019. 143 p.

METHODS OF PHARMACOLOGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION CURRENT APPROACHES TO THE PATIENTS MANAGEMENT

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Kardiologiia. KlinMed Consulting. Vol. 58. 2018. P. 82-93

PERSPECTIVE FOR USE OF THE RADIONUCLIDE DRUGS IN THE TREATMENT OF MALIGNANT TUMORS IN RUSSIA

Article

Zyryanov S.K., Zatolochina K.E.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2018. P. 51-57

MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS

Article

Kazakov A.S., Darmostukova M.A., Bukatina T.M., Snegireva I.I., Lepakhin V.K., Zatolochina K.E.

Безопасность и риск фармакотерапии. Федеральное государственное бюджетное учреждение "Научный центр экспертизы средств медицинского применения" Министерства здравоохранения Российской Федерации. Vol. 6. 2018. P. 118-122

LEVOFLOXACIN: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS FROM RUSSIAN SPONTANEOUS REPORT DATABASE

Article

ZYRYANOV S.K., ZATOLOCHINA K.E., ASETSKAYA I.L.

Antibiotiki i Khimioterapiya. Vol. 63. 2018. P. 46-51

A PROBLEM OF INHALED DRUG SUBSTITUTIONS: AN ANALYSIS OF DATA FROM RUSSIAN DATABASE ON ADVERSE EVENTS

Article

Zyryanov S.K., Zatolochina K.E., Asetskaya I.L.

Pulmonologiya. Medical Education. Vol. 28. 2018. P. 424-429

EFFICACIES AND CHEMICAL STRUCTURES OF MODERN DRUGS FOR HEPATITIS C VIRUS TREATMENT

Article

Kazakov A.S., Lepakhin V.K., Bukatina T.M., Snegireva I.I., Zatolochina K.É.

Pharmaceutical Chemistry Journal. Vol. 52. 2018. P. 497-500

GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION?

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Ima-Press Publishing House. Vol. 10. 2018. P. 75-80

РИВАРОКСАБАН: СРАВНИТЕЛЬНЫЙ АНАЛИЗ НЕЖЕЛАТЕЛЬНЫХ РЕАКЦИЙ В РОССИЙСКОЙ И МЕЖДУНАРОДНОЙ БАЗАХ ДАННЫХ

Article

Затолочина К.Э., Казаков А.С., Колесникова Е.Ю., Поливанов В.А., Аляутдин Р.Н., Романов Б.К., Олефир Ю.В.

Klinicheskaya Meditsina. Vol. 95. 2017. P. 451-456

Затолочина К.Э.

List of records

SAFETY AND TOLERABILITY OF NSAIDS: FOCUS ON ACECLOFENAC

SERIOUS ADVERSE DRUG REACTIONS WITH LETHAL OUTCOMES: ANALYSIS OF THE RUSSIAN PHARMACOVIGILANCE DATABASE

INTERNATIONAL DRUG SAFETY MONITORING

MURAMYLDIPEPTIDE - BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE

ANALYSIS OF ADVERSE DRUG REACTIONS IN ELDERLY PATIENTS ACCORDING TO THE DATABASE OF SPONTANEOUS REPORTS

INTERFERON BETA: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS AND EVALUATION OF POSSIBILITY OF SIGNAL IDENTIFICATION

THE ANALYSIS OF ADVERSE DRUG REACTIONS IN THE ELDERLY PATIENTS

METHODS OF PHARMACOLOGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION CURRENT APPROACHES TO THE PATIENTS MANAGEMENT

PERSPECTIVE FOR USE OF THE RADIONUCLIDE DRUGS IN THE TREATMENT OF MALIGNANT TUMORS IN RUSSIA

MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS

LEVOFLOXACIN: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS FROM RUSSIAN SPONTANEOUS REPORT DATABASE

A PROBLEM OF INHALED DRUG SUBSTITUTIONS: AN ANALYSIS OF DATA FROM RUSSIAN DATABASE ON ADVERSE EVENTS

EFFICACIES AND CHEMICAL STRUCTURES OF MODERN DRUGS FOR HEPATITIS C VIRUS TREATMENT

GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION?

РИВАРОКСАБАН: СРАВНИТЕЛЬНЫЙ АНАЛИЗ НЕЖЕЛАТЕЛЬНЫХ РЕАКЦИЙ В РОССИЙСКОЙ И МЕЖДУНАРОДНОЙ БАЗАХ ДАННЫХ

Other authors

Alekseenko E.A.

Pereverzev A.P.